Thursday and Friday, 20 and 21 January 2022, 5:30 – 7:00 PM (IST)
For: Technology Transfer Professionals (Organizers reserve right to select participants)
About the speaker: Dr Ashley Stevens D.Phil (Oxon), CLP, RTTP. President Focus IP Group, LLC, USA and Former Lecturer Strategy and Innovation Department, School of Management, Boston University, USA.
The Focus IP Group provides a variety of consulting services in intellectual property matters, including serving as an Expert Witness in intellectual property disputes, technology scouting, technology transfer and teaching the commercialization of early-stage technologies. For 15 years, Dr. Stevens led Boston University’s Office of Technology Transfer. He then became Special Assistant to the Vice President for Research for two years before retiring from full time employment at BU. He remains a Lecturer in the Strategy and Innovation Department in Boston University’s School of Management, where he teaches two graduate level, inter-disciplinary courses on Technology Commercialization. Before joining Boston University, he was Director of the Office of Technology Transfer at the Dana-Farber Cancer Institute, a teaching affiliate of the Harvard Medical School. During his tenure at Boston University, the Office of Technology Development spun out over 50 companies based on the University’s research, a number of which raised substantial amounts of capital, and the University’s licensing income climbed steadily. He is a Guest Professor at Osaka University, Japan, where he teaches G-TEC, an intensive summer course on technology commercialization. He has also taught in Chile, China and India.
Prior to entering the technology transfer profession, Dr. Stevens worked in the biotechnology industry for nearly ten years. He was a co-founder of Kytogenics, Inc., of which he is still a director, was co-founder of Genmap, Inc., and was Vice President of Business Development for BioTechnica International. He started his career with The Procter & Gamble Company, where he held a number of positions in commercial development, sales, marketing, product management, strategic planning and acquisitions and mergers.
Dr. Stevens publishes and lectures frequently on many aspects of technology transfer, including the Bayh-Dole Act, the economic impact of technology transfer and its role in economic development, the contribution of academia to the discovery of new drugs and vaccines, the role of technology transfer in global health and technology valuation. He was the recipient of the Bayh-Dole Award at the Association of University Technology Managers (AUTM) 2007 Annual Meeting and became President of AUTM in March 2010. He is also active in the Licensing Executives Society and the MassBio. Dr. Stevens holds a Bachelor of Arts in Natural Sciences, a Master of Arts and a Doctor of Philosophy in Physical Chemistry from Oxford University. He is a Certified Licensing Professional and a Registered Technology Transfer Professional.